Santen Pharmaceutical Co Stock Probability of Future Pink Sheet Price Finishing Over 14.73
| SNPHY Stock | USD 9.23 0.20 2.12% |
Santen |
Santen Pharmaceutical Target Price Odds to finish over 14.73
The tendency of Santen Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 14.73 or more in 90 days |
| 9.23 | 90 days | 14.73 | close to zero percent |
Based on a normal probability distribution, the odds of Santen Pharmaceutical to move over $ 14.73 or more in 90 days from now is close to zero percent (This Santen Pharmaceutical Co probability density function shows the probability of Santen Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Santen Pharmaceutical price to stay between its current price of $ 9.23 and $ 14.73 at the end of the 90-day period is over 95.87 .
Assuming the 90 days horizon Santen Pharmaceutical has a beta of 0.36. This usually implies as returns on the market go up, Santen Pharmaceutical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Santen Pharmaceutical Co will be expected to be much smaller as well. Additionally Santen Pharmaceutical Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Santen Pharmaceutical Price Density |
| Price |
Predictive Modules for Santen Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Santen Pharmaceutical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Santen Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Santen Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Santen Pharmaceutical is not an exception. The market had few large corrections towards the Santen Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Santen Pharmaceutical Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Santen Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.15 | |
β | Beta against NYSE Composite | 0.36 | |
σ | Overall volatility | 0.34 | |
Ir | Information ratio | -0.07 |
Santen Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Santen Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Santen Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Santen Pharmaceutical generated a negative expected return over the last 90 days |
Santen Pharmaceutical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Santen Pink Sheet often depends not only on the future outlook of the current and potential Santen Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Santen Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 400.4 M | |
| Cash And Short Term Investments | 84.3 B |
Santen Pharmaceutical Technical Analysis
Santen Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Santen Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Santen Pharmaceutical Co. In general, you should focus on analyzing Santen Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Santen Pharmaceutical Predictive Forecast Models
Santen Pharmaceutical's time-series forecasting models is one of many Santen Pharmaceutical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Santen Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Santen Pharmaceutical
Checking the ongoing alerts about Santen Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Santen Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Santen Pharmaceutical generated a negative expected return over the last 90 days |
Check out Santen Pharmaceutical Backtesting, Santen Pharmaceutical Valuation, Santen Pharmaceutical Correlation, Santen Pharmaceutical Hype Analysis, Santen Pharmaceutical Volatility, Santen Pharmaceutical History as well as Santen Pharmaceutical Performance. Note that the Santen Pharmaceutical information on this page should be used as a complementary analysis to other Santen Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Santen Pink Sheet analysis
When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |